openPR Logo
Press release

OTC Drug Market Report Research : 2017

09-06-2017 11:46 AM CET | Health & Medicine

Press release from: REPORTSANDMARKETS

/ PR Agency: REPORTSANDMARKETS
otc drug market size, otc drug market, otc drug market trends, otc drug market share, otc drug market analysis, the worldwide over

otc drug market size, otc drug market, otc drug market trends, otc drug market share, otc drug market analysis, the worldwide over

Reports And Markets Publish a New Market Research Report On –" OTC Drug Market Report Research : 2017"

Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-otc-drug-market-report-2017-1541262

In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific OTC Drug market competition by top manufacturers/players, with OTC Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Class A
Class B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of OTC Drug for each application, includin
Hospital
Clinic
Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Request For Sample Report @ https://www.reportsandmarkets.com/sample-request/asia-pacific-otc-drug-market-report-2017-1541262

Table of Contents

Asia-Pacific OTC Drug Market Report 2017
1 OTC Drug Overview
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug by Product Category
1.2.1 Asia-Pacific OTC Drug Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Class A
1.2.4 Class B
1.3 Asia-Pacific OTC Drug Market by Application/End Users
1.3.1 Asia-Pacific OTC Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Asia-Pacific OTC Drug Market by Region
1.4.1 Asia-Pacific OTC Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of OTC Drug (2012-2022)
1.5.1 Asia-Pacific OTC Drug Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific OTC Drug Revenue and Growth Rate (2012-2022)

2 Asia-Pacific OTC Drug Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific OTC Drug Market Competition by Players/Suppliers
2.1.1 Asia-Pacific OTC Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific OTC Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific OTC Drug (Volume and Value) by Type
2.2.1 Asia-Pacific OTC Drug Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific OTC Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific OTC Drug (Volume) by Application
2.4 Asia-Pacific OTC Drug (Volume and Value) by Region
2.4.1 Asia-Pacific OTC Drug Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific OTC Drug Revenue and Market Share by Region (2012-2017)

3 China OTC Drug (Volume, Value and Sales Price)
3.1 China OTC Drug Sales and Value (2012-2017)
3.1.1 China OTC Drug Sales Volume and Growth Rate (2012-2017)
3.1.2 China OTC Drug Revenue and Growth Rate (2012-2017)
3.1.3 China OTC Drug Sales Price Trend (2012-2017)
3.2 China OTC Drug Sales Volume and Market Share by Type
3.3 China OTC Drug Sales Volume and Market Share by Application

4 Japan OTC Drug (Volume, Value and Sales Price)
4.1 Japan OTC Drug Sales and Value (2012-2017)
4.1.1 Japan OTC Drug Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan OTC Drug Revenue and Growth Rate (2012-2017)
4.1.3 Japan OTC Drug Sales Price Trend (2012-2017)
4.2 Japan OTC Drug Sales Volume and Market Share by Type
4.3 Japan OTC Drug Sales Volume and Market Share by Application

5 South Korea OTC Drug (Volume, Value and Sales Price)
5.1 South Korea OTC Drug Sales and Value (2012-2017)
5.1.1 South Korea OTC Drug Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea OTC Drug Revenue and Growth Rate (2012-2017)
5.1.3 South Korea OTC Drug Sales Price Trend (2012-2017)
5.2 South Korea OTC Drug Sales Volume and Market Share by Type
5.3 South Korea OTC Drug Sales Volume and Market Share by Application

6 Taiwan OTC Drug (Volume, Value and Sales Price)
6.1 Taiwan OTC Drug Sales and Value (2012-2017)
6.1.1 Taiwan OTC Drug Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan OTC Drug Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan OTC Drug Sales Price Trend (2012-2017)
6.2 Taiwan OTC Drug Sales Volume and Market Share by Type
6.3 Taiwan OTC Drug Sales Volume and Market Share by Application

7 India OTC Drug (Volume, Value and Sales Price)
7.1 India OTC Drug Sales and Value (2012-2017)
7.1.1 India OTC Drug Sales Volume and Growth Rate (2012-2017)
7.1.2 India OTC Drug Revenue and Growth Rate (2012-2017)
7.1.3 India OTC Drug Sales Price Trend (2012-2017)
7.2 India OTC Drug Sales Volume and Market Share by Type
7.3 India OTC Drug Sales Volume and Market Share by Application

8 Southeast Asia OTC Drug (Volume, Value and Sales Price)
8.1 Southeast Asia OTC Drug Sales and Value (2012-2017)
8.1.1 Southeast Asia OTC Drug Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia OTC Drug Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia OTC Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia OTC Drug Sales Volume and Market Share by Type
8.3 Southeast Asia OTC Drug Sales Volume and Market Share by Application

9 Australia OTC Drug (Volume, Value and Sales Price)
9.1 Australia OTC Drug Sales and Value (2012-2017)
9.1.1 Australia OTC Drug Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia OTC Drug Revenue and Growth Rate (2012-2017)
9.1.3 Australia OTC Drug Sales Price Trend (2012-2017)
9.2 Australia OTC Drug Sales Volume and Market Share by Type
9.3 Australia OTC Drug Sales Volume and Market Share by Application

10 Asia-Pacific OTC Drug Players/Suppliers Profiles and Sales Data
10.1 Bayer HealthCare
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 OTC Drug Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline (GSK)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 OTC Drug Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Johnson&Johnson
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 OTC Drug Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Pfizer
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 OTC Drug Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Sanofi
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 OTC Drug Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 AstraZeneca
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 OTC Drug Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 BioGaia
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 OTC Drug Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Bristol Myers Squibb
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 OTC Drug Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Bukwang Pharmaceutica
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 OTC Drug Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Chr. Hansen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 OTC Drug Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Cipla
10.12 CoLucid
10.13 Daiichi Sankyo
10.14 Friggs
10.15 DSM
10.16 Eisai
10.17 Eli Lilly
10.18 Herbalife
10.19 Euradite

11 OTC Drug Manufacturing Cost Analysis
11.1 OTC Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of OTC Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 OTC Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific OTC Drug Market Forecast (2017-2022)
15.1 Asia-Pacific OTC Drug Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific OTC Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific OTC Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific OTC Drug Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific OTC Drug Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific OTC Drug Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific OTC Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific OTC Drug Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer

Check Discount @ https://www.reportsandmarkets.com/check-discount/asia-pacific-otc-drug-market-report-2017-1541262

For more information or any query mail at sales@reportsandmarkets.com

About Reports And Markets

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Person

Sanjay Jain

Manager - Partner Relations & International Marketing

info@reportsandmarkets.com

Ph: +1-214-377-1121 (US), +44-020-3286-9338 (UK)

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Drug Market Report Research : 2017 here

News-ID: 700229 • Views:

More Releases from REPORTSANDMARKETS

Micro Hotels Market Is Expected to Boom | Nine Hours in Japan, Dean Hotel Dublin, Tommie Hotels NYC
Micro Hotels Market Is Expected to Boom | Nine Hours in Japan, Dean Hotel Dublin …
This report studies the Micro Hotels Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Micro Hotels Market analysis segmented by companies, region, type and applications in the report. New vendors in the market are facing tough competition from established international vendors
IT Consulting and Integration Services Market Overview by Advance Technology, Future Outlook 2028 - Fujistu Ltd., AT&T Business, Huawei Technologies Co., Ltd., Deloitte
IT Consulting and Integration Services Market Overview by Advance Technology, Fu …
This report studies the IT Consulting and Integration Services Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete IT Consulting and Integration Services Market analysis segmented by companies, region, type and applications in the report. The report offers valuable insight into the
Bumping Services Market Growth, Overview with Detailed Analysis 2022-2028| ASE Group, Amkor Technology, UMC, TFME, JCET, Union Semiconductor, HT-TECH, and more
Bumping Services Market Growth, Overview with Detailed Analysis 2022-2028| ASE G …
This report studies the Bumping Services market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Bumping Services market analysis segmented by companies, region, type and applications in the report. New vendors in the market are facing tough competition from established international vendors
Laser Powder Bed Fusion (LPBF) Technology Market Overview by Advance Technology, Future Outlook 2028- Höganäs, IRPD, BEAMIT Group, EOS, SLM Solutions, Trumpf, Renishaw
Laser Powder Bed Fusion (LPBF) Technology Market Overview by Advance Technology, …
This report studies the Laser Powder Bed Fusion (LPBF) Technology market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Laser Powder Bed Fusion (LPBF) Technology market analysis segmented by companies, region, type and applications in the report. New vendors in the market

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current